🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-525825-19-00
Completed Phase I

A study to test how BI 3034701 is taken up and processed by the body in healthy men with normal weight or overweight

2026-525825-19-00 · tracked via the Priya Life Science EU tracker
Sponsor
Boehringer Ingelheim International GmbH
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
14/08/2026
Enrollment target
8
Sites
Hungary

Condition studied

Healthy

Eligibility

Age group
18-64 years, 65+ years
Sex
Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525825-19-00 on CTIS ↗ ← All trials in the EU